Open access
1,339
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer
Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
Lijia Oua Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China;b Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
, Chang Sua Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China;b Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
, Liang Lianga Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China;c Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, ChinaView further author information
, Qintong Duanb Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
, Yufeng Lib Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaView further author information
, Hui Zangd Department of Human Anatomy and Histoembryology of School of Basic Medical Sciences, Yiyang Medical College, Yiyang, Hunan, ChinaView further author information
, Yizi Hea Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, ChinaView further author information
, Ruolan Zenga Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, ChinaView further author information
, Yajun Lia Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, ChinaView further author information
, Hui Zhoua Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
View further author information
& View further author information
Ling Xiaob Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-0893-1777View further author information
Article: 2267865
|
Received 31 May 2023, Accepted 04 Oct 2023, Published online: 16 Oct 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.